1. Home
  2. ALKS vs GATX Comparison

ALKS vs GATX Comparison

Compare ALKS & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • GATX
  • Stock Information
  • Founded
  • ALKS 1987
  • GATX 1898
  • Country
  • ALKS Ireland
  • GATX United States
  • Employees
  • ALKS N/A
  • GATX N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • GATX Transportation Services
  • Sector
  • ALKS Health Care
  • GATX Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • GATX Nasdaq
  • Market Cap
  • ALKS 5.4B
  • GATX 5.6B
  • IPO Year
  • ALKS 1991
  • GATX N/A
  • Fundamental
  • Price
  • ALKS $33.02
  • GATX $155.21
  • Analyst Decision
  • ALKS Buy
  • GATX Buy
  • Analyst Count
  • ALKS 13
  • GATX 2
  • Target Price
  • ALKS $39.50
  • GATX $162.50
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • GATX 150.0K
  • Earning Date
  • ALKS 04-30-2025
  • GATX 04-22-2025
  • Dividend Yield
  • ALKS N/A
  • GATX 1.57%
  • EPS Growth
  • ALKS 3.47
  • GATX 9.27
  • EPS
  • ALKS 2.17
  • GATX 7.78
  • Revenue
  • ALKS $1,557,632,000.00
  • GATX $1,585,500,000.00
  • Revenue This Year
  • ALKS N/A
  • GATX $10.19
  • Revenue Next Year
  • ALKS $4.37
  • GATX $5.72
  • P/E Ratio
  • ALKS $15.10
  • GATX $19.96
  • Revenue Growth
  • ALKS N/A
  • GATX 12.38
  • 52 Week Low
  • ALKS $22.90
  • GATX $122.00
  • 52 Week High
  • ALKS $36.45
  • GATX $168.89
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 42.12
  • GATX 44.46
  • Support Level
  • ALKS $33.22
  • GATX $152.66
  • Resistance Level
  • ALKS $34.45
  • GATX $160.29
  • Average True Range (ATR)
  • ALKS 0.96
  • GATX 3.01
  • MACD
  • ALKS -0.23
  • GATX 0.39
  • Stochastic Oscillator
  • ALKS 28.87
  • GATX 53.26

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About GATX GATX Corporation

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

Share on Social Networks: